Home/Filings/4/0000930413-11-007263
4//SEC Filing

Rackear Andrew D. 4

Accession 0000930413-11-007263

CIK 0000727510other

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 5:09 PM ET

Size

5.4 KB

Accession

0000930413-11-007263

Insider Transaction Report

Form 4
Period: 2011-11-10
Rackear Andrew D.
VP and General Counsel
Transactions
  • Sale

    Common Stock

    2011-11-10$6.68/sh3,766$25,15748,334 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.68 to $6.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Documents

1 file

Issuer

ENZON PHARMACEUTICALS INC

CIK 0000727510

Entity typeother

Related Parties

1
  • filerCIK 0001408617

Filing Metadata

Form type
4
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 5:09 PM ET
Size
5.4 KB